Moon J. Noh, Ph.D.

Moon J. Noh, Ph.D.

Chief Executive Officer

Dr. Moon J. Noh has been with Kolon TissueGene for over 16 years. Prior to his role here, Dr. Noh was the Director of the Biotechnology Lab at Kolon Central Research Park. Dr. Noh holds a Ph.D. and M.S. from the Korea Advanced Institute of Science and Technology in Molecular Biology.

Sung Han, Ph,D.

Sung Han, Ph,D.

Chief Executive Officer

Sung Han joined Kolon TissueGene, Inc. in March, 2020 as the co-Chief Executive Officer. Currently he serves as the CTO of Kolon Group. Before he joined Kolon Group, he served as the Technology Director of Corporate Innovationin Eastman Chemical Company. He received his Ph.D. degree in the Nuclear Engineering at University of California, Berkeley, CA.

Jung In Kim

Jung In Kim

Chief Financial Officer

Jung In Kim joined Kolon TissueGene, Inc. in December, 2021 as the Chief Financial Officer and the Korea Branch leader. Before she joined Kolon TissueGene, she served as a director of the Management and Finance division in Kolon Corporation. She received his Bachelor of Arts in Mathematics at Kookmin University in Korea and acquired her CPA license from Korea Institute of Certified Public Accountant.

SunJoo Lee, Ph.D.

SunJoo Lee, Ph.D.

Outside Director

In addition to his roles as the Outside Director at Kolon TissueGene, SunJoo Lee also serves as the Professor in Gynecologic Oncology, Konkuk University School of Medicine. He received his Ph. D. degree from Chung-Ang University, School of Medicine, Pharmacology and M.D. degree from Seoul National University, School of Medicine, Seoul, Korea.

Young J. Kim, Ph.D.

Young J. Kim, Ph.D.

Statutory Auditor

Young J. Kim’s founded and successfully led companies in the U.S. commercial and government service industries for many years. He received his Doctorate in Engineering Management at George Washington University.